Adverse events ‐ treatment failure · adults with renal vasculitis
Pulse cyclophosphamide showed no clear difference in adverse events ‐ treatment failure compared with continuous cyclophosphamide (low certainty).
1 finding from 1 review
Serious infections · adults with renal vasculitis
Pulse cyclophosphamide showed no clear difference in serious infections compared with continuous cyclophosphamide (low certainty).
1 finding from 1 review
Death at final · adults with renal vasculitis
Pulse cyclophosphamide showed no clear difference in death at final compared with continuous cyclophosphamide (low certainty).
1 finding from 1 review
Serum creatinine (mg/dL) · adults with renal vasculitis
1 finding from 1 review
Primary: investigator‐rated good/excellent control of symptoms · people with hand eczema, continuously for 6 months, significant disability, inadequate response to conventional treatment, confirmation by…
Oral immunosuppressants: oral cyclosporin showed no clear difference in primary: investigator‐ rated good/excellent control of symptomsb compared with topical betamethasone dipropionate (moderate certainty).
1 finding from 1 review
Primary: participant‐rated good/excellent control of symptoms · people with hand eczema, continuously for 6 months, significant disability, inadequate response to conventional treatment, confirmation by…
Oral immunosuppressants: oral cyclosporin showed no clear difference in primary: participant‐rated good/excellent control of symptomsb compared with topical betamethasone dipropionate (moderate certainty).
1 finding from 1 review
Number of participants with any adverse event (primary tolerability outcome) · people with hand eczema, continuously for 6 months, significant disability, inadequate response to conventional treatment, confirmation by…
Oral immunosuppressants: oral cyclosporin showed no clear difference in primary: adverse events ‐ at least 1 adverse event compared with topical betamethasone dipropionate (moderate certainty).
1 finding from 1 review
Secondary: investigator‐rated reduction in severity ‐ DASIb · people with hand eczema, continuously for 6 months, significant disability, inadequate response to conventional treatment, confirmation by…
1 finding from 1 review
Daytime sleepiness (ESS): change from baseline. · adults with obstructive sleep apnoea
1 finding from 1 review
AHI · adults with obstructive sleep apnoea
1 finding from 1 review
Self‐reported adherence time · adults with obstructive sleep apnoea
1 finding from 1 review
Adverse effects · adults with obstructive sleep apnoea
1 finding from 1 review
Quality of life Assessed using SF‐36 or FOSQ · adults with obstructive sleep apnoea
1 finding from 1 review
Sleep quality Assessed by average duration of slow‐wave and REM sleep periods · adults with obstructive sleep apnoea
1 finding from 1 review
Cognitive dysfunction · adults with obstructive sleep apnoea
1 finding from 1 review
Intervention not reported
WORK PARTICIPATION · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention probably leads to higher WORK PARTICIPATION (moderate certainty).
1 finding from 1 review
Intervention not reported
IMPORTANT RECOVERY · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention may leads to higher IMPORTANT RECOVERY (low certainty).
1 finding from 1 review
Intervention not reported
FUNCTIONAL LIMITATIONS · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
It is very uncertain whether the intervention changes FUNCTIONAL LIMITATIONS (very low certainty).
1 finding from 1 review
Intervention not reported
PAIN INTENSITY · People with non‐specific low back pain presenting to healthcare, occupational, general or mixed populations Prognostic factor: Individual…
The intervention may leads to higher PAIN INTENSITY (low certainty).
1 finding from 1 review
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · adults with refractory glaucoma
1 finding from 1 review